Sign In
Buy VIVO
$3.90
+0.170 (+4.56%)
At Close: Aug 04, 2026
Abbott's (ABT) Q1 Earnings and Revenues Exceed Estimates
02:23pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Within Adult Nutrition, Abbott (ABT) gains from the strong performance of Ensure and Glucerna brands in Q1.
Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?
12:48pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Robust global demand for Oncotype DX and increased Cologuard orders are likely to have driven Exact Sciences' (EXAS) Q1 performance.
Edwards Lifesciences (EW) to Post Q1 Earnings: What's in Store?
12:47pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) first-quarter performance.
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
01:20pm, Monday, 18'th Apr 2022 Zacks Investment Research
Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q1 on the continuous rollout of Alinity, Abbott's suite of diagnostic instru
Quest Diagnostics (DGX) Q1 Earnings to Grow on Base Business
01:03pm, Monday, 18'th Apr 2022 Zacks Investment Research
Quest Diagnostics (DGX) is expected to report a strong first half of Q1 with a growing number of cases and then a dull second half on gradual stabilization in testing demand.
Zacks.com featured highlights include Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group
12:06pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group are part of Screen of the Week article.
What Makes Meridian Bioscience (VIVO) a Good Fit for "Trend Investing"
12:50pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
Meridian Bioscience (VIVO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed th
Bet on These 4 Low-Beta Stocks to Combat Market Volatility
12:45pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), OP Bancorp (OPBK) and United Fire Group (UFCS) are well poised to gain.
What Makes Meridian Bioscience (VIVO) a Good Fit for "Trend Investing"
10:32am, Wednesday, 06'th Apr 2022
Meridian Bioscience (VIVO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed th
Bet on These 4 Low-Beta Stocks to Combat Market Volatility
09:47am, Wednesday, 06'th Apr 2022
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), OP Bancorp (OPBK) and United Fire Group (UFCS) are well poised to gain.
New Strong Buy Stocks for March 25th
11:43am, Friday, 25'th Mar 2022 Zacks Investment Research
CLH, VIVO, EOG, TGT, and COLM have been added to the Zacks Rank #1 (Strong Buy) List on March 25, 2022.
New Strong Buy Stocks for March 25th
09:02am, Friday, 25'th Mar 2022
CLH, VIVO, EOG, TGT, and COLM have been added to the Zacks Rank #1 (Strong Buy) List on March 25, 2022.
Zacks.com featured highlights include Meridian Bioscience, OP Bancorp, ICU Medical and Pangaea Logistics Solutions
12:03pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Meridian Bioscience, OP Bancorp, ICU Medical and Pangaea Logistics Solutions have been highlighted in this Screen of the Week article.
Buy These 4 Low-Beta Stocks to Combat the Choppy Market
10:53am, Wednesday, 23'rd Mar 2022 Zacks Investment Research
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), OP Bancorp (OPBK), ICU Medical (ICUI) and Pangaea Logistics (PANL) are well poised to gain.
New Strong Buy Stocks for March 22nd
12:25pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
AA, HLI, RUSHA, COLM, and VIVO have been added to the Zacks Rank #1 (Strong Buy) List on March 22, 2022.
